APA (7 ম সংস্করণ) উদ্ধৃতি

Taylor, P., Christensen, R., Moosavi, S., Selema, P., Guilatco, R., Fowler, H., . . . Haraoui, B. (2019). Real-world safety data from patients with rheumatic diseases treated with CT-P13, an infliximab biosimilar: An interim analysis from an observational study. BMJ Journals.

শিকাগো স্টাইল (17 তম সংস্করণ) উদ্ধৃতি

Taylor, P., R. Christensen, S. Moosavi, P. Selema, R. Guilatco, H. Fowler, C. Bombardier, এবং B. Haraoui. Real-world Safety Data from Patients with Rheumatic Diseases Treated with CT-P13, an Infliximab Biosimilar: An Interim Analysis from an Observational Study. BMJ Journals, 2019.

M.L.A (9 ম সংস্করণ) উদ্ধৃতি

Taylor, P., et al. Real-world Safety Data from Patients with Rheumatic Diseases Treated with CT-P13, an Infliximab Biosimilar: An Interim Analysis from an Observational Study. BMJ Journals, 2019.

সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.